Opesinkast 5 OPV tablets for preventive and chronic bronchial treatment (4 blisters x 7 tablets)

Dosage form Box of 4 blisters x 7 tablets
Specifications Montelukast

Ingredient

Composition information	Content
Montelukast	5mg

Uses

indications

opesinkast drugs are indicated in the following cases:

Preventive and treat chronic bronchial asthma for adults and children aged 12 months and older, including preventing day and night asthma symptoms, treating asthma sensitive to aspirin. Reducing day and night symptoms of allergic rhinitis (seasonal allergic rhinitis in adults and children 2 years and older and allergic rhinitis year -round in adults and children aged 6 months and older.

pharmacokinetics

No information.

Before taking Opesinkast 5 OPV tablets for preventive and chronic bronchial treatment (4 blisters x 7 tablets)

How to use

OPESINAST drugs are taken orally.

Dosage

Opesinkast is taken once a day at full or hungry. To treat asthma, should take medicine in the evening. With allergic rhinitis time, the medication time depends on the needs of each patient. For patients who have both asthma and allergic rhinitis should take 1 capsule every day in the evening.

Patients aged 15 and older with asthma and/or allergic rhinitis

1 tablet daily 10 mg or 2 tablets 5 mg.

Children 6 to 14 years old have asthma and/or allergic rhinitis

1 tablet daily 5 mg.

Children from 6 months to 5 years old have asthma and/or allergic rhinitis

1 tablet daily 4 mg.

Preventive bronchospasm due to exertion

Children from 6 to 14 years old: Take at least 2 hours before the testing test, 1 tablet 5 mg.

aged 15 years and older: Take at least 2 hours before the test of exertion, 1 tablet of 10 mg or 2 tablets of 5 mg.

General recommendations

Opesinkast's treatment effect on asthma test parameters will be achieved within 1 day, it is necessary to tell patients to continue using Opesinkast, although asthma attacks have been controlled, as well as in periods of severe asthma. There is no need to adjust the dose for patients with renal failure, mild and medium liver failure, the elderly, or for each gender.

Opesinkast treatment is related to other asthma drugs

Opesinkast can be used in combination with other treatments. Sudden replacement of inhaled corticosteroids or drinking with opesinkast.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

No report.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using opesinkast, you may experience unwanted effects (ADR).

Very common, ADR ≥ 1/10

Bacterial infection: upper respiratory infection.

Common, 1/100 ≤ ADR

Digestive: diarrhea, nausea, vomiting.

liver: Increased serum transaminase level (ALT, AST).

DA: Ban. general: fever.

Uncommon, 1/1000 ≤ ADR

Immune: The hypersensitivity reaction includes anaphylactic shock.

Mental: Abnormal dreams include nightmares, insomnia, sleepwalking, anxiety, agitation, including aggressive or hostile, depression, irritability, restlessness, tremor.

Central nerve: dizziness, drowsiness, abnormal/decreased sensation, epilepsy.

Respiratory: Nosebleeds.

digestive: dry mouth, indigestion. Skin: Purple, urticaria, itching.

Muscle muscle: joint pain, muscle pain includes cramps.

General: weakness, fatigue, discomfort, edema.

Rare, 1/10000 ≤ ADR

Blood: tends to increase bleeding.

Mental Mental: distraction, memory loss. Cardiovascular: Heart beat fast. skin: angioedema.

Very rare, ADR

Immunology: Eosin hypernagus in the liver.

Self -mental: illusion, disorientation, suicide thoughts and suicide behavior.

Respiratory: Churg - Strauss syndrome (CSS), EOSIN hyperthyens in the lungs.

liver: Hepatitis (including bile, liver cells, liver damage).

Skin: Red nodules, diverse roses.

Instructions on how to handle ADR

consult your doctor if you have unwanted effects when using the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Opesinkast drug contraindicated in the following cases:

Hypersensitivity to any ingredients of the drug.

Be cautious when using

If asthma or shortness of breath is getting worse, it is necessary to notify the doctor immediately.

Do not use Montelukast oral forms to treat acute asthma attacks. The disease should be told to use the appropriate drugs available.

Can reduce inhaled corticosteroids with a doctor's supervision, but must not suddenly replace oral corticosteroid or inhaled with Montelukast.

Must be vigilant with any signs of Churg - Strauss syndrome.

Do not take aspirin or anti -inflammatory drugs (such as nonsteroidal anti -inflammatory drugs) if they make asthma attack worse.

There is no study of the safety and effectiveness of the drug in children under 6 months old.

The ability to drive and operate machinery

There is no basis to prove Montelukast affects the ability to drive or operate machinery. However, some side effects (such as dizziness and drowsiness) have been reported very rare that can affect the ability to drive or operate machinery of some patients.

Pregnancy

has not been studied in pregnant women. Montelukast is only used during pregnancy if you have carefully considered.

Breastfeeding period

It is unclear whether Montelukast is excreted through breast milk or not. Therefore, this drug can only be used for breastfeeding women if considered carefully.

Medicinal interaction

can be used Monteukast with other commonly used drugs in preventive and chronic treatment of asthma and allergic rhinitis. In studies on drug interactions, Montelukast's clinical recommendations do not significantly affect the pharmacokinetics of the following drugs: Theophyllin, Prednison, Prednisolon, Birth contraceptive drugs (Norethindron 1 mg/ethinyl estradiol 35 mcg), Terfenadin, Digoxin and Warfarin.Montelukast's under the curve (AUC) area decreased by about 40% in users simultaneously with phenobarbital. Because Montelukast is metabolized by CYP 3A4, it is necessary to be cautious, especially in children when Montelukast used simultaneously with drugs metabolized by CYP 3A4 such as Phenytoin, Phenobarbital and Rifampicin.

Storage

Store at temperatures below 30 ° C, in a dry place, avoiding light.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.